Literature DB >> 28167834

Mtss1(CSC156) mutant mice fail to display efficient Mtss1 protein depletion.

D Fahrenkamp1, O Herrmann1, S Koschmieder1, T H Brümmendorf1, M Schemionek1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28167834     DOI： 10.1038/leu.2017.19

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

1.  MTSS1 is a metastasis driver in a subset of human melanomas.

Authors:  Kirsten D Mertz; Gaurav Pathria; Christine Wagner; Juha Saarikangas; Andrea Sboner; Julia Romanov; Melanie Gschaider; Florian Lenz; Friederike Neumann; Wolfgang Schreiner; Maria Nemethova; Alexander Glassmann; Pekka Lappalainen; Georg Stingl; J Victor Small; Dieter Fink; Lynda Chin; Stephan N Wagner
Journal:  Nat Commun       Date:  2014-03-17       Impact factor: 14.919

2.  Mice deficient in MIM expression are predisposed to lymphomagenesis.

Authors:  D Yu; X H Zhan; X F Zhao; M S Williams; G B Carey; E Smith; D Scott; J Zhu; Y Guo; S Cherukuri; C I Civin; X Zhan
Journal:  Oncogene       Date:  2011-11-14       Impact factor: 9.867

3.  MTSS1, a novel target of DNA methyltransferase 3B, functions as a tumor suppressor in hepatocellular carcinoma.

Authors:  H Fan; L Chen; F Zhang; Y Quan; X Su; X Qiu; Z Zhao; K L Kong; S Dong; Y Song; T H M Chan; X-Y Guan
Journal:  Oncogene       Date:  2011-09-12       Impact factor: 9.867

4.  Missing-in-metastasis MIM/MTSS1 promotes actin assembly at intercellular junctions and is required for integrity of kidney epithelia.

Authors:  Juha Saarikangas; Pieta K Mattila; Markku Varjosalo; Miia Bovellan; Janne Hakanen; Julia Calzada-Wack; Monica Tost; Luise Jennen; Birgit Rathkolb; Wolfgang Hans; Marion Horsch; Mervi E Hyvönen; Nina Perälä; Helmut Fuchs; Valérie Gailus-Durner; Irene Esposito; Eckhard Wolf; Martin Hrabé de Angelis; Mikko J Frilander; Harri Savilahti; Hannu Sariola; Kirsi Sainio; Sanna Lehtonen; Jussi Taipale; Marjo Salminen; Pekka Lappalainen
Journal:  J Cell Sci       Date:  2011-03-15       Impact factor: 5.285

5.  Murine missing in metastasis (MIM) mediates cell polarity and regulates the motility response to growth factors.

Authors:  Dan Yu; Xiaoguo H Zhan; Shuqiong Niu; Irina Mikhailenko; Dudley K Strickland; Jianwei Zhu; Meng Cao; Xi Zhan
Journal:  PLoS One       Date:  2011-06-09       Impact factor: 3.240

6.  Identification of the Adapter Molecule MTSS1 as a Potential Oncogene-Specific Tumor Suppressor in Acute Myeloid Leukemia.

Authors:  Mirle Schemionek; Behzad Kharabi Masouleh; Yvonne Klaile; Utz Krug; Katja Hebestreit; Claudia Schubert; Martin Dugas; Thomas Büchner; Bernhard Wörmann; Wolfgang Hiddemann; Wolfgang E Berdel; Tim H Brümmendorf; Carsten Müller-Tidow; Steffen Koschmieder
Journal:  PLoS One       Date:  2015-05-21       Impact factor: 3.240

7.  MIM regulates the trafficking of bone marrow cells via modulating surface expression of CXCR4.

Authors:  T Zhan; C Cao; L Li; N Gu; C I Civin; X Zhan
Journal:  Leukemia       Date:  2016-02-29       Impact factor: 11.528

8.  Mtss1 is a critical epigenetically regulated tumor suppressor in CML.

Authors:  M Schemionek; O Herrmann; M M Reher; N Chatain; C Schubert; I G Costa; S Hänzelmann; E G Gusmao; S Kintsler; T Braunschweig; A Hamilton; G V Helgason; M Copland; A Schwab; C Müller-Tidow; S Li; T L Holyoake; T H Brümmendorf; S Koschmieder
Journal:  Leukemia       Date:  2015-12-01       Impact factor: 11.528
  8 in total
  3 in total

1.  MTSS1/Src family kinase dysregulation underlies multiple inherited ataxias.

Authors:  Alexander S Brown; Pratap Meera; Banu Altindag; Ravi Chopra; Emma M Perkins; Sharan Paul; Daniel R Scoles; Eric Tarapore; Jessica Magri; Haoran Huang; Mandy Jackson; Vikram G Shakkottai; Thomas S Otis; Stefan M Pulst; Scott X Atwood; Anthony E Oro
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-07       Impact factor: 11.205

2.  Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia.

Authors:  Oliver Herrmann; Maja Kim Kuepper; Marlena Bütow; Ivan G Costa; Iris Appelmann; Fabian Beier; Tom Luedde; Till Braunschweig; Steffen Koschmieder; Tim H Brümmendorf; Mirle Schemionek
Journal:  BMC Cancer       Date:  2019-07-04       Impact factor: 4.430

3.  Missing-in-Metastasis/Metastasis Suppressor 1 Regulates B Cell Receptor Signaling, B Cell Metabolic Potential, and T Cell-Independent Immune Responses.

Authors:  Alexey V Sarapulov; Petar Petrov; Sara Hernández-Pérez; Vid Šuštar; Elina Kuokkanen; Lena Cords; Rufus V M Samuel; Marika Vainio; Marco Fritzsche; Yolanda R Carrasco; Pieta K Mattila
Journal:  Front Immunol       Date:  2020-04-16       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.